IMMUNOMODULATORY ALPHA NEUTROPHIL (IMAN)
LIVE

Serial Number

98095871

Owner

LIfT BioSciences Limited

Attorney

Steven E. Lauridsen

Filing Date

Jul 21, 2023

Add to watchlist:

No watchlists yet
View on USPTO

IMMUNOMODULATORY ALPHA NEUTROPHIL (IMAN) Trademark

Serial Number: 98095871 • Registration: 7765108

IMMUNOMODULATORY ALPHA NEUTROPHIL (IMAN) is a trademark filed by LIfT BioSciences Limited on July 21, 2023. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

LIfT BioSciences Limited (3 trademarks)

Translation & Innovation Hub Imperial
London W120BZ

Entity Type: 03

Trademark Details

Filing Date

July 21, 2023

Registration Date

April 22, 2025

Published for Opposition

March 4, 2025

Goods & Services

Biotechnological immune cell preparations for medical use; all of the aforesaid being for use in cell therapy, living cell therapy and the treatment of cancer

Chemicals for use in biotechnological manufacturing processes; Chemicals for use in biotechnological product development; Chemical substances for use in the biotechnological industry; media for cell culture for research use in the biotechnological industry; Chemical reagents for use in biotechnology, other than for medical or veterinary use; all of the aforesaid being for use in cell therapy, living cell therapy and the treatment of cancer

Biotechnological research; Biotechnology research; Research relating to biotechnology; Biotechnological research relating to industry; Research and development in the field of biotechnology; Research and development in the pharmaceutical and biotechnology fields; Information on the subject of scientific research in the field of biochemistry and biotechnology; all of the aforesaid relating to cell therapy, living cell therapy and the treatment of cancer

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 22, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Apr 22, 2025 R.PR
PUBLISHED FOR OPPOSITION
Mar 4, 2025 PUBO
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 4, 2025 NPUB
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 26, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 6, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 5, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 5, 2025 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Feb 5, 2025 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Feb 3, 2025 GNFN
FINAL REFUSAL E-MAILED
Feb 3, 2025 GNFR
FINAL REFUSAL WRITTEN
Feb 3, 2025 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 23, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 23, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 23, 2024 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Oct 30, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Oct 30, 2024 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 31, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jul 31, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jul 31, 2024 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 1, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 1, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 1, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 29, 2024 GNRN
NON-FINAL ACTION E-MAILED
Mar 29, 2024 GNRT
NON-FINAL ACTION WRITTEN
Mar 29, 2024 CNRT
ASSIGNED TO EXAMINER
Mar 26, 2024 DOCK
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Jan 28, 2024 AMPX
ASSIGNED TO LIE
Jan 25, 2024 ALIE
TEAS VOLUNTARY AMENDMENT RECEIVED
Sep 6, 2023 PARI
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 21, 2023 NWOS
NEW APPLICATION ENTERED
Jul 25, 2023 NWAP